Market Tracker

09/30 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

During the Trading Day
1.53 -0.06 / -3.77%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.54 +0.01 / +0.65%
 
Volume: 66.0K

Today’s Trading

Previous close1.59
Today’s open1.60
Day’s range1.52 - 1.61
Volume4,158,826
Average volume (3 months)5,458,699
Market cap$310.2M
Dividend yield--
Data as of 3:59pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-7.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book4.43

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...+0.32+1.78%
QLTIQLT Inc-0.15-3.21%
ENZEnzo Biochem Inc-0.03-0.58%
BSTCBiospecifics Technol...+0.86+2.50%
Data as of 4:01pm ET, 09/30/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts